REED ELIZABETH E sold TVTX
September 22, 2025 · Form 4 insider transaction
REED ELIZABETH E sold 10,000 shares of Travere Therapeutics, Inc. at $25.00 per share, a transaction worth $250.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$25.00
Total value
$250.0K
InsiderREED ELIZABETH E
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 22, 2025
Filing dateSeptember 24, 2025
Shares owned after89,878
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option grant to the Reporting Person on January 4, 2017 with an expiration date of January 4, 2027.